Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-16 Sale |
2024-04-17 7:22 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $38.42 | $768,390 | 261,606 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-13 5:22 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $41.95 | $839,100 | 244,484 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-28 6:49 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $39.75 | $794,923 | 224,714 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-18 4:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $36 | $720,000 | 211,681 (Direct) |
View |
| 2023-12-12 Sale |
2023-12-13 7:48 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $40.01 | $800,262 | 251,681 (Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 4:18 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $39.43 | $788,670 | 179,269 (Direct) |
View |
| 2023-10-17 Sale |
2023-10-17 7:28 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $36.52 | $365,200 | 193,010 (Direct) |
View |
| 2023-09-19 Sale |
2023-09-19 4:09 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $39.1 | $390,980 | 203,010 (Direct) |
View |
| 2023-08-29 Sale |
2023-08-31 5:35 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $42.69 | $1,280,730 | 983,666 (Direct) |
View |
| 2023-08-22 Sale |
2023-08-23 5:08 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $42.41 | $424,070 | 218,590 (Direct) |
View |
| 2023-08-15 Sale |
2023-08-17 5:29 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $43.49 | $1,304,820 | 1,073,666 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-15 4:04 pm |
HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director |
20,000 | $43.73 | $874,520 | 20,503 (Direct) |
View |
| 2023-07-25 Sale |
2023-07-27 4:03 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $43.09 | $1,292,750 | 1,163,666 (Direct) |
View |
| 2023-07-18 Sale |
2023-07-19 4:10 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $40.43 | $404,300 | 261,868 (Direct) |
View |
| 2023-06-21 Sale |
2023-06-22 6:20 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $36 | $360,000 | 159,416 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-25 Option Award |
2024-04-29 6:11 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
15,305 | $0 | 128,559 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:08 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director |
15,305 | $0 | 29,576 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:05 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
15,305 | $0 | 202,309 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 6:01 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Krishnan Mahesh Director |
15,305 | $0 | 15,305 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:56 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
15,305 | $0 | 62,415 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:54 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
15,305 | $0 | 24,558 (Direct) |
View |
| 2024-04-25 Option Award |
2024-04-29 5:51 pm |
N/A 2034-04-25 |
HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director |
15,305 | $0 | 55,591 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-17 7:22 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 261,606 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-17 7:22 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $8.11 | 261,606 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,436 | $12.07 | 229,891 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
292 | $16.78 | 229,891 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A 2027-02-22 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
11,618 | $0 | 229,891 (Direct) |
View |
| 2024-03-26 Exercise |
2024-03-26 7:38 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,890 | $8.11 | 229,891 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-13 5:22 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
16,449 | $12.07 | 244,484 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-13 5:22 pm |
N/A 2027-02-22 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 244,484 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-13 5:22 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
3,551 | $8.11 | 244,484 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-28 6:49 pm |
N/A 2026-02-03 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
7,471 | $0 | 224,714 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-28 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
7,471 | $8.11 | 224,714 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:12 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
38,659 | $0 | 38,659 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:08 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
57,109 | $0 | 57,109 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:05 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
54,473 | $0 | 54,473 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 5:01 pm |
2025-02-23 2034-02-23 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
182,746 | $0 | 182,746 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:59 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,376 | $0 | 194,100 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:59 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,257 | $36.1 | 194,100 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:55 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
4,796 | $0 | 26,068 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:55 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
2,577 | $36.1 | 26,068 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
10,422 | $0 | 41,653 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:53 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,601 | $36.1 | 41,653 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-20 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
37,884 | $0 | 769,386 (Direct) |
View |
| 2024-02-16 Tax Withholding |
2024-02-20 6:49 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
20,362 | $36.1 | 769,386 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 5:47 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,479 | $0 | 167,354 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:47 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
3,386 | $0 | 167,354 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:47 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,040 | $35.91 | 167,354 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,254 | $0 | 11,913 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:41 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
686 | $35.91 | 11,913 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 5:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
32,781 | $0 | 672,314 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-16 5:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
13,092 | $0 | 672,314 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 5:39 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
24,655 | $35.91 | 672,314 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,133 | $0 | 157,143 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,901 | $35.49 | 157,143 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,502 | $0 | 10,091 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,477 | $35.49 | 10,091 (Direct) |
View |
| 2024-02-10 Exercise |
2024-02-13 4:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
31,281 | $0 | 638,004 (Direct) |
View |
| 2024-02-10 Tax Withholding |
2024-02-13 4:12 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
16,943 | $35.49 | 638,004 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 4:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $12.07 | 211,681 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-18 4:07 pm |
N/A 2027-02-22 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 211,681 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-05 4:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
7,611 | $0 | 24,683 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-05 4:04 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
2,957 | $35.78 | 24,683 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-13 7:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
11,467 | $12.07 | 251,681 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-13 7:48 pm |
N/A 2025-02-04 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 251,681 (Direct) |
View |
| 2023-12-12 Exercise |
2023-12-13 7:48 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,533 | $13.81 | 251,681 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
1,708 | $16.78 | 179,269 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:18 pm |
N/A 2025-02-04 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 179,269 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 4:18 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
18,292 | $13.81 | 179,269 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-17 7:28 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $19.98 | 193,010 (Direct) |
View |
| 2023-10-17 Exercise |
2023-10-17 7:28 pm |
N/A 2030-02-10 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 193,010 (Direct) |
View |
| 2023-09-19 Exercise |
2023-09-19 4:09 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $19.98 | 203,010 (Direct) |
View |
| 2023-09-19 Exercise |
2023-09-19 4:09 pm |
N/A 2030-02-10 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 203,010 (Direct) |
View |
| 2023-08-29 Exercise |
2023-08-31 5:35 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $13.87 | 983,666 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-23 5:08 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
8,075 | $19.98 | 218,590 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-23 5:08 pm |
N/A 2028-02-14 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 218,590 (Direct) |
View |
| 2023-08-22 Exercise |
2023-08-23 5:08 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
1,925 | $18.41 | 218,590 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-17 5:29 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $13.87 | 1,073,666 (Direct) |
View |
| 2023-07-25 Exercise |
2023-07-27 4:03 pm |
N/A 2025-02-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $13.87 | 1,163,666 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-19 4:10 pm |
N/A 2028-02-14 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
20,000 | $0 | 261,868 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-19 4:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $18.41 | 261,868 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-19 4:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,825 | $8.11 | 261,868 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-19 4:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
7,175 | $13.81 | 261,868 (Direct) |
View |
| 2023-06-21 Exercise |
2023-06-22 6:20 pm |
N/A 2028-02-14 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 159,416 (Direct) |
View |
| 2023-06-21 Exercise |
2023-06-22 6:20 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $18.41 | 159,416 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:27 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
19,436 | $0 | 124,625 (Direct) |
View |